RU2017108908A - Замещенное в положении c-4" макролидное производное - Google Patents

Замещенное в положении c-4" макролидное производное Download PDF

Info

Publication number
RU2017108908A
RU2017108908A RU2017108908A RU2017108908A RU2017108908A RU 2017108908 A RU2017108908 A RU 2017108908A RU 2017108908 A RU2017108908 A RU 2017108908A RU 2017108908 A RU2017108908 A RU 2017108908A RU 2017108908 A RU2017108908 A RU 2017108908A
Authority
RU
Russia
Prior art keywords
substituted
macrolide derivative
compound
solvate
hydrate
Prior art date
Application number
RU2017108908A
Other languages
English (en)
Inventor
Томохиро СУГИМОТО
Масато ХАЯСИ
Таканори КАВАГУТИ
Original Assignee
Тайсо Фармасьютикал Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Тайсо Фармасьютикал Ко., Лтд. filed Critical Тайсо Фармасьютикал Ко., Лтд.
Publication of RU2017108908A publication Critical patent/RU2017108908A/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Claims (5)

1. Соединение, представленное формулой [1]:
Figure 00000001
или его фармацевтически приемлемая соль, или его гидрат или сольват.
2. Фармацевтическая композиция, содержащая соединение, выбранное из группы, состоящей из соединения, его фармацевтически приемлемой соли и его гидрата и сольвата по п. 1.
3. Антибактериальное средство, содержащее соединение, выбранное из группы, состоящей из соединения, его фармацевтически приемлемой соли и его гидрата и сольвата по п. 1.
RU2017108908A 2014-08-18 2015-08-17 Замещенное в положении c-4" макролидное производное RU2017108908A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2014165848 2014-08-18
JP2014-165848 2014-08-18
PCT/JP2015/072993 WO2016027755A1 (ja) 2014-08-18 2015-08-17 C-4"位置換マクロライド化合物

Publications (1)

Publication Number Publication Date
RU2017108908A true RU2017108908A (ru) 2018-09-21

Family

ID=55350700

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017108908A RU2017108908A (ru) 2014-08-18 2015-08-17 Замещенное в положении c-4" макролидное производное

Country Status (19)

Country Link
US (1) US20170267708A1 (ru)
EP (1) EP3192798A4 (ru)
JP (1) JP5874871B1 (ru)
KR (1) KR20170036106A (ru)
CN (1) CN106573953A (ru)
AR (1) AR102810A1 (ru)
AU (1) AU2015304439A1 (ru)
BR (1) BR112017000606A2 (ru)
CA (1) CA2957628A1 (ru)
CL (1) CL2017000395A1 (ru)
CO (1) CO2017002440A2 (ru)
IL (1) IL250559A0 (ru)
MX (1) MX2017002223A (ru)
PE (1) PE20170467A1 (ru)
PH (1) PH12017500223A1 (ru)
RU (1) RU2017108908A (ru)
SG (1) SG11201701146TA (ru)
TW (1) TW201625656A (ru)
WO (1) WO2016027755A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017142002A1 (ja) * 2016-02-17 2017-08-24 大正製薬株式会社 C-4"位置換マクロライド化合物フリー体及び塩の結晶形並びにそれらの製造方法
CN114231430B (zh) * 2021-06-11 2024-02-09 常州大学 一种红霉素降解菌iurm f57及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54967A (en) 1977-06-06 1979-01-06 Mitsubishi Electric Corp Output circuit
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
KR100523679B1 (ko) 1996-09-04 2005-10-26 아보트 러보러터리즈 항균 활성을 지닌 6-o-치환된 케톨라이드
HN1998000074A (es) 1997-06-11 1999-01-08 Pfizer Prod Inc Derivados de macrolidos c-4 sustituidos
UY26964A1 (es) 2000-10-16 2002-06-20 Abbott Lab Derivados de eritromicina 6-0-sustituidos con mayor tolerancia gastrointestinal
AR085286A1 (es) * 2011-02-21 2013-09-18 Taisho Pharmaceutical Co Ltd Derivado de macrolido sustituido en la posicion c-4
JP2014058508A (ja) * 2012-08-20 2014-04-03 Taisho Pharmaceutical Co Ltd 9位オキシム置換マクロライド誘導体
JP2014058507A (ja) * 2012-08-20 2014-04-03 Taisho Pharmaceutical Co Ltd 11位アミノ置換マクロライド誘導体
JP5857008B2 (ja) * 2012-08-20 2016-02-10 大正製薬株式会社 C−4”位置換マクロライド誘導体を含有する医薬

Also Published As

Publication number Publication date
KR20170036106A (ko) 2017-03-31
WO2016027755A1 (ja) 2016-02-25
EP3192798A1 (en) 2017-07-19
PH12017500223A1 (en) 2017-07-10
CA2957628A1 (en) 2016-02-25
JP5874871B1 (ja) 2016-03-02
AR102810A1 (es) 2017-03-29
EP3192798A4 (en) 2018-01-03
CN106573953A (zh) 2017-04-19
AU2015304439A1 (en) 2017-03-16
BR112017000606A2 (pt) 2017-11-07
CL2017000395A1 (es) 2018-01-05
PE20170467A1 (es) 2017-04-26
CO2017002440A2 (es) 2017-04-28
IL250559A0 (en) 2017-03-30
MX2017002223A (es) 2017-05-09
TW201625656A (zh) 2016-07-16
SG11201701146TA (en) 2017-03-30
US20170267708A1 (en) 2017-09-21
JPWO2016027755A1 (ja) 2017-04-27

Similar Documents

Publication Publication Date Title
RU2021133039A (ru) Молекулы, применимые в качестве пестицидов, и связанные с ними промежуточные продукты, композиции и способы
JP2014221779A5 (ru)
CN106536480A8 (zh) 吡咯烷‑2,5‑二酮衍生物、药物组合物及用作ido1抑制剂的方法
HRP20210529T1 (hr) Inhibitori za mk2 i njihove uporabe
MX2021003311A (es) Sondas para la proyeccion de imagen de la proteina huntingtina.
DK3328843T3 (da) 1,3,4-oxadiazolsulfonamidderivat-forbindelser som histon- deacetylase-6-inhibitor, og den farmaceutske sammensætning
WO2014152389A8 (en) Imaging agent for detection of diseased cells
JP2013532130A5 (ru)
MX2018009459A (es) Derivado de sulfonamida y composicion farmaceutica que contiene el mismo.
WO2015000431A9 (zh) 替唑尼特氨基甲酸酯及其在药学中的应用
MX2021005891A (es) Sondas para la proyeccion de imagen de la proteina huntingtina.
BR112015019587A2 (pt) combinações compreendendo compostos maba e corticosteroides
MX2017007573A (es) Composicion acuosa novedosa.
RU2018101431A (ru) Ингибиторы индоламин-2,3-диоксигеназы
JP2015042663A5 (ru)
CA2922375C (en) Alpha-tea salt forms: compositions and uses for treating disease
EA201492029A1 (ru) N-этил-4-гидроксил-1-метил-5-(метил(2,3,4,5,6-пентагидроксигексил)амино)-2-оксо-n-фенил-1,2-дигидрохинолин-3-карбоксамид
AR090073A1 (es) N-etil-n-fenil-1,2-dihidro-4,5-di-hidroxi-1-metil-2-oxo-3-quinolinacarboxamida, su preparacion y usos
EA201692270A1 (ru) Производные нафтиридиндиона
WO2015130547A8 (en) Bis-cyclic guanidine compound compositions, methods of use and treatment thereof
WO2015002755A3 (en) Compounds for the treatment of malaria
RU2017108908A (ru) Замещенное в положении c-4" макролидное производное
WO2016006974A3 (en) Novel triazolopyrimidinone or triazolopyridinone derivatives, and use thereof
WO2016006975A3 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
BR112017024126B8 (pt) Composições farmacêuticas, composto a micronizado e/ou pelo menos um sal farmaceuticamente aceitável micronizado do composto a e uso dos mesmos